Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 202323 | 2-aminopyrazolo[1,5-a]pyridine-3-carboxylic acid | 1542020-25-6 | 98% Min. |  |
| 2062319 | 1-acetyl-5-nitro-3H-indol-2-one | 114985-63-6 | 98% Min. | |
| 2061313 | 1-acetyl-5-amino-2-indolinone | 422518-10-3 | 98% Min. | |
| 2062312 | (4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate | 2098497-32-4 | 98% Min. | |
| 2062311 | 8-Acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one | 1035299-32-3 | 98% Min. | |
| 2062307 | 2-Amino-5-cyanopyrazine | 113305-94-5 | 98% Min. | |
| 2062025 | 5-amino-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxylic acid | 1452226-14-0 | 96% Min. |  |
| 2062009 | AT13148 intermediate(N1) | 1056901-64-4 | 96% Min. |  |
| 2061701 | Anacetrapib | 875446-37-0 | 98% Min. |  |
| Anacetrapib, also known as MK-0859, is a CETP inhibitor being developed to treat hype | ||||
| 2061308 | Ambrisentan | 177036-94-1 | 98% Min. |  |
| Ambrisentan, also known as BSF-208075 and LU-208075, is a drug indicated for use in t | ||||
| 206101 | AZD0364 | 2097416-76-5 | 98% Min. | |
| AZD-0364 is a potent and selectiveERK2inhibitor extracted from patent WO2017080979A1, | ||||
| 2051515 | Asapiprant | 932372-01-5 | 98% Min. |  |
| Asapiprant is a potent and selective DP1 receptor antagonist, with a Ki of 0.44 nM. A | ||||
| 2051513 | AKOS B018304 | 6308-22-1 | 98% Min. | |
| AKOS B018304 is a potent inhibitor of chikungunya virus with low micro molar activity. | ||||
| 23178 | AC-90179 HCl | 359878-19-6 | 98% Min. |  |
| AC-90179 is a high selective 5-hydroxytryptamine2A receptor inverse agonist. It is an | ||||
| S-203043 | 6-AMINOISOQUINOLINE | 23687-26-5 | 96% Min. |  |
| 204605 | A134974 | 186141-75-3 | 98% Min. |  |
| A134974 is a bioactive chemical. | ||||
| 204604 | A-1293201 | 1375557-33-7 | 98% Min. |  |
| A-1293201 is a potent and selective NAMPT inhibitor. | ||||
| 204603 | A-119637 | 255713-47-4 | 98% Min. |  |
| A-119637 is a novel, selective and potent alpha1D antagonist. | ||||
| 204602 | A-1048400 | 1219624-62-0 | 98% Min. |  |
| A-1048400 is a potent and selective N-type and T-type calcium channel blocker. | ||||
| 204601 | A-1062 | 1821-13-2 | 98% Min. |  |
| A-1062 is a resolvase-binding inhibitor. A1062 inhibits resolvase binding to the res | ||||
| 112193 | AMG-510 | 2296729-00-3 | 98% Min. |  |
| AMG-510 is a potent KRAS G12C covalent inhibitor. AMG-510 selectively targets the KRA | ||||
| 112194 | AMG-510 racemate | 2252403-56-6 | 98% Min. |  |
| AMG-510 is a potent KRAS G12C covalent inhibitor. AMG-510 selectively targets the KRA | ||||
| 112191 | Aprocitentan | 1103522-45-7 | 98% Min. |  |
| Aprocitentan is an orally active, dual endothelin (ET) receptor antagonist developed | ||||
| 6111903 | Aramchol | 246529-22-6 | 98% Min. |  |
| Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With | ||||
| 513191 | Acibenzolar acid | 35272-27-6 | 96% Min. |  |
| benzo[d][1,2,3]thiadiazole-7-carboxylic acid,Acibenzolar acid,CGA 210 007 | ||||
| 193291 | AR-C155858 | 496791-37-8 | >98% |  |
| AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that b | ||||
| 193288 | ACT-709478 | 1838651-58-3 | >98% |  |
| ACT-709478 is a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate | ||||
| 193287 | A1874 | 2064292-12-0 | >98% |  |
| A1874 is a nutlin-based and BRD4-degrading PROTAC which induces BRD4 degradation in c | ||||
| 193254 | AZD9567 | 1893415-00-3 | >98% |  |
| AZD9567 is an oral differentiated non-steroidal selective glucocorticoid receptor mod | ||||
| 193222 | AZ1495 | 2196204-23-4 | >98% |  |
| AZ1495 is a potent and selective IRAK4 inhibitor. | ||||